Early PKD Observational Cohort Study
NCT02936791
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Polycystic Kidney Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 4 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Kansas Medical Center
- Last updated on ClinicalTrials.gov
- April 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- University of Chicago · Chicago, IL
Kansas · 1
- University of Kansas Medical Center · Kansas City, KS
Missouri · 1
- Children's Mercy Hospital · Kansas City, MO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.